Peregrine Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $209k | 32k | 6.50 |
| 2023-09-30 | $304k | 32k | 9.44 |
| 2023-06-30 | $450k | 32k | 13.97 |
| 2023-03-31 | $604k | 32k | 18.76 |
| 2022-12-31 | $443k | 32k | 13.77 |
| 2022-09-30 | $615k | 32k | 19.12 |
| 2022-06-30 | $543k | 36k | 15.26 |
| 2022-03-31 | $725k | 36k | 20.37 |
| 2021-12-31 | $692k | 24k | 29.18 |
| 2021-09-30 | $511k | 24k | 21.55 |
| 2021-06-30 | $608k | 24k | 25.64 |
| 2021-03-31 | $432k | 24k | 18.23 |
| 2020-12-31 | $182k | 16k | 11.54 |
| 2020-09-30 | $149k | 20k | 7.64 |
| 2020-06-30 | $203k | 31k | 6.58 |
| 2020-03-31 | $158k | 31k | 5.11 |
| 2019-12-31 | $237k | 31k | 7.68 |
| 2019-09-30 | $164k | 31k | 5.31 |
| 2019-06-30 | $173k | 31k | 5.60 |
| 2018-12-31 | $107k | 26k | 4.09 |
| 2018-09-30 | $278k | 41k | 6.85 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors